BEVACIZUMAB AND FOTEMUSTINE AS SALVAGE THERAPY IN RECURRENT GLIOBLASTOMA: A PHASE II MULTICENTER ITALIAN STUDY

被引：0
|
作者：
Trevisan, E. [1 ]
Ruda, R. [1 ]
Picco, E. [1 ]
Crasto, S. Greco [2 ]
Caroli, M. [3 ]
Fabrini, A. [4 ]
Scotti, V. [4 ]
Lolli, I.
Guarneri, D. [1 ]
Soffietti, R. [1 ]
机构：
[1] Neurooncol Dept, Turin, Italy
[2] Dept Radiol, Turin, Italy
[3] Dept Neurosurg, Turin, Italy
[4] Dept Radiotherapy, Pisa, Italy
来源：
NEURO-ONCOLOGY | 2010年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：49 / 50
页数：2
相关论文
共 50 条
  • [21] Recurrent spinal cord glioblastoma: salvage therapy with bevacizumab
    Chamberlain, Marc C.
    Johnston, Sandra K.
    JOURNAL OF NEURO-ONCOLOGY, 2011, 102 (03) : 427 - 432
  • [22] BEVACIZUMAB AND NITROSOUREA IN PATIENTS WITH RECURRENT MALIGNANT GLIOMA: A PHASE II MULTICENTER ITALIAN STUDY
    Ruda, Roberta
    Trevisan, Elisa
    Picco, Elisabetta
    Guarneri, Daniele
    Caroli, Manuela
    Fabrini, Maria G.
    Scotti, Valerio
    Soffietti, Riccardo
    NEURO-ONCOLOGY, 2009, 11 (06) : 905 - 905
  • [23] Phase II study of bevacizumab and nitrosourea in patients with recurrent malignant glioma: A multicenter Italian study
    Soffietti, R.
    Ruda, R.
    Trevisan, E.
    Picco, E.
    Guarneri, D.
    Caroli, M.
    Fabrini, M.
    Scotti, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [24] Efficacy and safety study of fotemustine and bevacizumab in patients with recurrent glioblastoma.
    Escudero, Laura Sanchez
    Urbano, Maria Amor
    Garces, Maria Yeray Rodriguez
    Murillo, Fatima Toscano
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [25] PHASE II STUDY OF REGORAFENIB IN BEVACIZUMAB REFRACTORY RECURRENT GLIOBLASTOMA
    Rauf, Yasmeen
    Schilero, Cathy
    Peereboom, David
    Ahluwalia, Manmeet
    NEURO-ONCOLOGY, 2020, 22 : 33 - 33
  • [26] Phase II study of bevacizumab and vorinostat for recurrent glioblastoma.
    Ghiaseddin, Ashley
    Reardon, David A.
    Massey, Woody
    Mannerino, Alexandra
    Lipp, Eric S.
    Herndon, James E.
    McSherry, Frances
    Desjardins, Annick
    Randazzo, Dina M.
    Vlahovic, Gordana
    Friedman, Henry S.
    Peters, Katherine B.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [27] PHASE II STUDY OF PANOBINOSTAT IN COMBINATION WITH BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA
    Lee, Eudocia
    Reardon, David
    Schiff, David
    Drappatz, Jan
    Muzikansky, Alona
    Hammond, Samantha
    Grimm, Sean
    Norden, Andrew
    Beroukhim, Rameen
    McCluskey, Christine
    Chi, Andrew
    Batchelor, Tracy
    Smith, Katrina
    Gaffey, Sarah
    Gerard, Mary
    Snodgras, Susan
    Raizer, Jeffrey
    Wen, Patrick
    NEURO-ONCOLOGY, 2013, 15 : 118 - 118
  • [28] Salvage therapy with bevacizumab and chemotherapy (irinotecan or fotemustine) in recurrent high-grade gliomas
    Trevisan, E.
    Laguzzi, E.
    Picco, E.
    Ruda, R.
    Crasto, S. Greco
    Gaidolfi, E.
    Fabrini, M. G.
    Scotti, V.
    Caroli, M.
    Bazzoli, E.
    Guarneri, D.
    Soffietti, R.
    JOURNAL OF NEUROLOGY, 2009, 256 : S53 - S53
  • [29] Recurrent spinal curd glioblastoma: Salvage therapy with bevacizumab.
    Johnston, S. K.
    Chamberlain, M. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] SALVAGE THERAPY WITH SINGLE-AGENT BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA
    Chamberlain, Marc C.
    Johnston, Sandra K.
    NEURO-ONCOLOGY, 2009, 11 (05) : 635 - 635
12345